OTC Trade Dress, Columns Possible Exemption Requests - FDA's Ganley
This article was originally published in The Rose Sheet
Executive Summary
Trade dress and the use of columns to present required label information would be two "interesting" areas for which industry could submit exemption requests under the OTC labeling rule, FDA Division of OTC Drugs Director Charles Ganley, MD, said at the Regulatory Affairs Professionals Society annual meeting in Washington, D.C. Oct. 5.
You may also be interested in...
CHPA Requests Two-Year Extension For OTC Labeling Final Rule
A two-year extension of the implementation deadlines for FDA's final rule on over-the-counter drug labeling is requested by the Consumer Healthcare Products Association in a citizen petition submitted to the agency Oct. 1.
CHPA Requests Two-Year Extension For OTC Labeling Final Rule
A two-year extension of the implementation deadlines for FDA's final rule on over-the-counter drug labeling is requested by the Consumer Healthcare Products Association in a citizen petition submitted to the agency Oct. 1.
Trade Dress Exemption Could Be Short-Term Fix To OTC Label Issues - CTFA
A general exemption for OTC products that meet a "clear and conspicuous" performance standard may be an "intermediate fix" for those that do not meet the color requirements in the OTC labeling rule, Cosmetic, Toiletry and Fragrance Association VP-Legal & General Counsel Thomas Donegan said. He spoke at an FDA working group meeting to discuss product labeling in Rockville, Md. Aug. 24.